Edition:
United Kingdom

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

11.09USD
3:56pm BST
Change (% chg)

$0.04 (+0.36%)
Prev Close
$11.05
Open
$11.08
Day's High
$11.12
Day's Low
$11.05
Volume
4,509
Avg. Vol
80,718
52-wk High
$17.80
52-wk Low
$9.23

Tung, Roger 

Dr. Roger Tung is the Co-Founder, President, Director and CEO of Concert Pharmaceuticals Inc. He is also a member of the board of directors of Flex Pharma, Inc., a public pharmaceutical company. Before founding Concert, Dr. Tung was a founding scientist at Vertex Pharmaceuticals Incorporated, a pharmaceutical company, where he was employed from 1989 to 2005, most recently as its Vice President of Drug Discovery. Prior to Vertex, he held various positions at Merck, Sharp & Dohme Research Laboratories, a global healthcare provider, and The Squibb Institute for Medicinal Chemistry. Dr. Tung received a B.A. in Chemistry from Reed College and a Ph.D. in Medicinal Chemistry from the University of Wisconsin-Madison. We believe that Dr. Tung’s detailed knowledge of our Company and his 34-year career in the global pharmaceutical and biotechnology industries, including his roles at Vertex, provide a critical contribution to our Board of Directors.

Basic Compensation

Total Annual Compensation, USD 535,511
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 4,072,340
Fiscal Year Total, USD 4,607,850

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

205,613

Roger Tung

4,607,850

Marc Becker

2,450,530

Nancy Stuart

1,908,030

James Cassella

1,960,240

Thomas Auchincloss

205,613
As Of  31 Dec 2018